SitesBLAST
Comparing RR42_RS29085 FitnessBrowser__Cup4G11:RR42_RS29085 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 19 hits to proteins with known functional sites (download)
P0AA76 D-galactonate transporter; D-galactonate/H(+) symporter from Escherichia coli (strain K12) (see paper)
41% identity, 98% coverage: 7:446/451 of query aligns to 1:429/430 of P0AA76
- Y29 (= Y35) binding
- D31 (= D37) mutation to N: Loss of galactonate transport activity.
- R32 (= R38) binding
- Y64 (= Y70) binding
- E118 (= E131) mutation to Q: Loss of galactonate transport activity.
- W358 (= W374) binding
6e9nA E. Coli d-galactonate:proton symporter in the inward open form (see paper)
41% identity, 94% coverage: 20:445/451 of query aligns to 3:409/409 of 6e9nA
6e9oA E. Coli d-galactonate:proton symporter mutant e133q in the outward substrate-bound form (see paper)
39% identity, 94% coverage: 20:445/451 of query aligns to 6:393/393 of 6e9oA
Q9JI12 Vesicular glutamate transporter 2; VGluT2; Differentiation-associated BNPI; Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter; Solute carrier family 17 member 6 from Rattus norvegicus (Rat) (see 2 papers)
27% identity, 84% coverage: 30:409/451 of query aligns to 93:465/582 of Q9JI12
- H128 (≠ F63) mutation to A: Greatly lowers L-glutamate transport.
- R184 (= R124) mutation R->A,E,K: Greatly lowers L-glutamate transport.
- E191 (= E131) mutation to A: Greatly lowers L-glutamate transport.; mutation E->D,Q: Lowers L-glutamate transport.
- R322 (≠ I268) mutation to A: Loss of L-glutamate release. Abolishes the chloride ion conductance.
Sites not aligning to the query:
- 88 R→A: Impairs synaptic transmission. Abolishes the chloride ion conductance.
7t3nA R184q/e191q mutant of rat vesicular glutamate transporter 2 (vglut2)
27% identity, 84% coverage: 30:409/451 of query aligns to 35:407/452 of 7t3nA
Sites not aligning to the query:
Q9NRA2 Sialin; H(+)/nitrate cotransporter; H(+)/sialic acid cotransporter; AST; Membrane glycoprotein HP59; Solute carrier family 17 member 5; Vesicular excitatory amino acid transporter; VEAT from Homo sapiens (Human) (see 8 papers)
26% identity, 79% coverage: 50:407/451 of query aligns to 99:443/495 of Q9NRA2
- K136 (≠ R87) to E: in SD; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; completely devoid of L-aspartate and L-glutamate transporter activity, but retains appreciable H(+)-coupled sialic acid transporter activity; dbSNP:rs80338795
- H183 (≠ A139) to R: in ISSD; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; abolishes H(+)-coupled sialic acid transporter activity; has normal L-aspartate and L-glutamate transporter activity; dbSNP:rs119491109
- LL 198:199 (≠ AS 154:155) mutation to AA: Localizes in vesicular structures mainly concentrated in the perinuclear region.
- I--------L 266:267 (≠ IKQGGGLIEM 221:230) mutation to LA: Localizes in vesicular structures mainly concentrated in the perinuclear region.
- SSLRN 268:272 (≠ SGDAG 231:235) natural variant: Missing (in ISSD; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; abolishes H(+)-coupled sialic acid transporter activity; has normal L-aspartate and L-glutamate transporter activity)
- G328 (= G295) to E: in ISSD; some patients may manifest a milder phenotype consistent with Salla disease; markedly decreases H(+)-coupled sialic acid transporter activity; abolishes L-aspartate and L-glutamate transporter activity; dbSNP:rs386833996
- P334 (= P301) to R: in ISSD; does not affect intracellular localization, targeted to lysosomes; abolishes H(+)-coupled sialic acid transporter activity; abolishes L-aspartate and L-glutamate transporter activity; dbSNP:rs119491110
- G371 (= G337) to V: in ISSD; abolishes H(+)-coupled sialic acid transporter activity; abolishes L-aspartate and L-glutamate transporter activity; dbSNP:rs777862172
Sites not aligning to the query:
- 22:23 Dileucine internalization motif; LL→AA: Targeted to plasma membrane.; LL→GG: Targeted to plasma membrane; sialic acid uptake strongly activated at acidic pH.
- 39 R → C: in SD; frequent variant in Finland; alters intracellular localization, only partially targeted to lysosomes and mainly detected in LAMP1-negative vesicles and in the Golgi apparatus; completely devoid of L-aspartate and L-glutamate transport activity, but retains appreciable H(+)-coupled sialic acid and nitrate transporter activity; dbSNP:rs80338794
Q8BN82 Sialin; H(+)/nitrate cotransporter; H(+)/sialic acid cotransporter; AST; Solute carrier family 17 member 5; Vesicular excitatory amino acid transporter; VEAT from Mus musculus (Mouse) (see paper)
27% identity, 79% coverage: 50:407/451 of query aligns to 99:443/495 of Q8BN82
- H183 (≠ A139) mutation to R: Abolishes sialic acid transporter activity. Does not affect L-aspartate and L-glutamate transporter activity.
Sites not aligning to the query:
- 39 R→C: Completely abolishes L-aspartate and L-glutamate transporter activity. Retains appreciable H(+)-coupled sialic acid transporter activity.
Q9Y2C5 Probable small intestine urate exporter; Solute carrier family 17 member 4 from Homo sapiens (Human) (see 2 papers)
24% identity, 84% coverage: 47:425/451 of query aligns to 98:464/497 of Q9Y2C5
- A372 (≠ V335) to T: in dbSNP:rs11754288
Sites not aligning to the query:
- 66 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N→A: Loss of glycosylation and significant reduction in the transport of thyroid hormones T3 and T4; when associated with A-75 and A-90.
- 75 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N→A: Loss of glycosylation and significant reduction in the transport of thyroid hormones T3 and T4; when associated with A-66 and A-90.
- 90 modified: carbohydrate, N-linked (GlcNAc...) asparagine; N→A: Loss of glycosylation and significant reduction in the transport of thyroid hormones T3 and T4; when associated with A-75 and A-90.
Q03567 Uncharacterized transporter slc-17.2 from Caenorhabditis elegans (see paper)
26% identity, 80% coverage: 51:411/451 of query aligns to 75:430/493 of Q03567
Sites not aligning to the query:
- 69 modified: carbohydrate, N-linked (GlcNAc...) asparagine
Q5Q0U0 Sialin; H(+)/nitrate cotransporter; H(+)/sialic acid cotransporter; AST; Solute carrier family 17 (Anion/sugar transporter), member 5; Vesicular excitatory amino acid transporter; VEAT from Rattus norvegicus (Rat) (see 2 papers)
26% identity, 79% coverage: 50:407/451 of query aligns to 99:443/495 of Q5Q0U0
- K136 (≠ R87) mutation to E: Markedly decreases H(+)-coupled sialic acid transporter activity.
- R168 (= R124) mutation to C: Abolishes H(+)-coupled sialic acid transporter activity.
- E171 (≠ V127) mutation to C: Decreases H(+)-coupled sialic acid transporter activity; when associated with C-175.
- G172 (= G128) mutation to C: Decreases protein levels and alters subcellular localization.
- E175 (= E131) mutation to C: Decreases H(+)-coupled sialic acid transporter activity; when associated with C-171.
- G176 (≠ S132) mutation to C: Decreases protein levels and alters subcellular localization.
- F179 (= F135) mutation to C: Decreases the affinity and transport rate for D-glucuronate. Does not affect H(+)-coupled sialic acid transporter activity.
- P180 (= P136) mutation to C: Decreases protein levels and alters subcellular localization.
- H183 (≠ A139) mutation to R: Abolishes H(+)-coupled sialic acid transporter activity.
- W186 (≠ V142) mutation to C: Abolishes H(+)-coupled sialic acid transporter activity.
- SSLKN 268:272 (≠ GKKDK 235:239) mutation Missing: Abolishes H(+)-coupled sialic acid transporter activity.
- P334 (= P301) mutation to R: Abolishes H(+)-coupled sialic acid transporter activity.
- G371 (= G337) mutation to V: Remains in the endoplasmic reticulum.
Sites not aligning to the query:
- 22:23 Dileucine internalization motif; LL→AA: Targeted to plasma membrane; sialic acid uptake strongly activated at acidic pH.
- 39 R→C: Markedly decreases H(+)-coupled sialic acid transporter activity.
Q5EXK5 3-hydroxybenzoate transporter MhbT from Klebsiella oxytoca (see paper)
23% identity, 99% coverage: 1:445/451 of query aligns to 5:436/452 of Q5EXK5
- D82 (= D82) mutation to A: Loss of activity.
- V311 (= V314) mutation to W: Loss of activity.
- D314 (= D317) mutation to A: Loss of activity.
A2SWM2 Sphingosine-1-phosphate transporter SPNS2; Protein spinster homolog 2; Protein two of hearts from Danio rerio (Zebrafish) (Brachydanio rerio) (see paper)
25% identity, 77% coverage: 33:379/451 of query aligns to 67:398/504 of A2SWM2
- R153 (= R124) mutation to S: In ko157; displays cardia bifida (2 hearts).
Q8IVW8 Sphingosine-1-phosphate transporter SPNS2; Protein spinster homolog 2 from Homo sapiens (Human) (see 2 papers)
25% identity, 84% coverage: 33:411/451 of query aligns to 114:482/549 of Q8IVW8
- R200 (= R124) mutation to S: Loss of function; does not rescue the cardia bifida phenotype in the morpholino knockdown in zebrafish.
- S319 (≠ Y262) natural variant: Missing (in DFNB115; uncertain significance; dbSNP:rs749994718)
8jhqA Cryo-em structure of human s1p transporter spns2 bound with s1p (see paper)
24% identity, 84% coverage: 33:411/451 of query aligns to 20:387/446 of 8jhqA
7yubR S1p-bound human spns2 (see paper)
24% identity, 84% coverage: 33:411/451 of query aligns to 22:370/429 of 7yubR
8g92A Structure of inhibitor 16d-bound spns2 (see paper)
25% identity, 84% coverage: 33:411/451 of query aligns to 16:358/415 of 8g92A
Q9GQQ0 Protein spinster; Protein benchwarmer; Protein diphthong from Drosophila melanogaster (Fruit fly) (see paper)
23% identity, 88% coverage: 20:417/451 of query aligns to 113:478/605 of Q9GQQ0
- E217 (= E131) mutation to K: In bnch(N); leads to storage in yolk spheres during oogenesis and results in widespread accumulation of enlarged lysosomal and late endosomal inclusions.
Q51955 4-hydroxybenzoate transporter PcaK from Pseudomonas putida (Arthrobacter siderocapsulatus) (see 2 papers)
25% identity, 30% coverage: 17:151/451 of query aligns to 24:149/448 of Q51955
- D41 (≠ N34) mutation D->A,N: Abolishes 4-HBA transport.; mutation to E: Decrease in 4-HBA transport.
- D44 (= D37) mutation D->A,N: Abolishes 4-HBA transport.; mutation to E: Decrease in 4-HBA transport.
- G85 (= G78) mutation to V: Abolishes 4-HBA transport and chemotaxis.
- D89 (= D82) mutation to N: Abolishes 4-HBA transport and chemotaxis.
- G92 (= G85) mutation to A: Decrease in 4-HBA transport and chemotaxis.; mutation to C: No change in 4-HBA transport and chemotaxis.; mutation G->L,V: Abolishes 4-HBA transport and chemotaxis.; mutation to Q: Decrease in 4-HBA transport and strong decrease in chemotaxis.
- R124 (= R124) mutation to A: Abolishes 4-HBA transport.
- E144 (≠ S144) mutation to A: Strong decrease in 4-HBA transport.
Sites not aligning to the query:
- 183 H→A: Decrease in 4-HBA transport and chemotaxis.
- 323 D→N: Abolishes 4-HBA transport and chemotaxis.
- 328 H→A: Decrease in 4-HBA transport and chemotaxis.; H→R: Decrease in 4-HBA transport and loss of chemotaxis.
- 386 R→A: Strong decrease in 4-HBA transport.
- 398 R→A: Abolishes 4-HBA transport.
- 444 H→A: No change in 4-HBA transport and chemotaxis.
7yudR Fty720p-bound human spns2 (see paper)
25% identity, 84% coverage: 33:411/451 of query aligns to 15:358/417 of 7yudR
Query Sequence
>RR42_RS29085 FitnessBrowser__Cup4G11:RR42_RS29085
MNLSNTINVAGEATRRSHVRYWILLMIFVVTTVNYADRATLSITGPAMRSEFGFDAVQMG
FIFSAFSWAYVMAQIPGGWLLDRFGARRIYACSIFLWSFFTLLQGFIGVFATVGAAVTTL
FVLRFAVGLAESPAFPANAKVVASWFPTAERGTASAIFNSAQYFAAVLFTPLMAWLTHAL
GWHHVYLWMGALGMVLAGLWLKVVRSPATHPGVNRAELDYIKQGGGLIEMSGDAGKKDKE
ASGTRWFYVRQLLSNRMLLGVYLGQYCINVLTYFFLTWFPVYLVQARGMSILKAGFVASL
PAICGFLGGVLGGVISDGFLRRGYSLTVARKVPIVAGMLLSVSMIACNYVDSEWLVVGFM
ALAFFGKGIGALGWAVVADTAPKEVIGLAGSIFNMFGNIAGIVTPIVIGYILGTTGSFNG
ALVFVGANALVTVISYLVIVKEIKRVELKHP
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory